CN105381128A - 一种辅助针灸治疗外周神经麻痹的中药冲剂及制备方法 - Google Patents
一种辅助针灸治疗外周神经麻痹的中药冲剂及制备方法 Download PDFInfo
- Publication number
- CN105381128A CN105381128A CN201510970171.1A CN201510970171A CN105381128A CN 105381128 A CN105381128 A CN 105381128A CN 201510970171 A CN201510970171 A CN 201510970171A CN 105381128 A CN105381128 A CN 105381128A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- blood
- chinese medicine
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 62
- 206010033799 Paralysis Diseases 0.000 title claims abstract description 25
- 238000001467 acupuncture Methods 0.000 title claims abstract description 23
- 238000000034 method Methods 0.000 title abstract description 3
- 210000000578 peripheral nerve Anatomy 0.000 title abstract 3
- 238000007654 immersion Methods 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 21
- 230000002093 peripheral effect Effects 0.000 claims description 20
- 210000000582 semen Anatomy 0.000 claims description 19
- 239000000203 mixture Substances 0.000 claims description 18
- 241000756943 Codonopsis Species 0.000 claims description 15
- 241000282376 Panthera tigris Species 0.000 claims description 15
- 241000255791 Bombyx Species 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000002245 particle Substances 0.000 claims description 12
- 239000004615 ingredient Substances 0.000 claims description 11
- 238000010410 dusting Methods 0.000 claims description 9
- 238000010298 pulverizing process Methods 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 7
- 238000009835 boiling Methods 0.000 claims description 6
- 238000001704 evaporation Methods 0.000 claims description 6
- 230000008020 evaporation Effects 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 235000019991 rice wine Nutrition 0.000 claims description 6
- 235000015099 wheat brans Nutrition 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 4
- 229920001353 Dextrin Polymers 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 3
- -1 after drying Substances 0.000 claims description 3
- 235000019504 cigarettes Nutrition 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 235000014101 wine Nutrition 0.000 claims description 3
- 239000008280 blood Substances 0.000 abstract description 79
- 210000004369 blood Anatomy 0.000 abstract description 77
- 210000004185 liver Anatomy 0.000 abstract description 37
- 210000003734 kidney Anatomy 0.000 abstract description 33
- 230000001737 promoting effect Effects 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 29
- 210000000952 spleen Anatomy 0.000 abstract description 27
- 210000000988 bone and bone Anatomy 0.000 abstract description 20
- 210000002435 tendon Anatomy 0.000 abstract description 18
- 238000005728 strengthening Methods 0.000 abstract description 14
- 230000003213 activating effect Effects 0.000 abstract description 13
- 230000002040 relaxant effect Effects 0.000 abstract description 11
- 238000010792 warming Methods 0.000 abstract description 7
- 230000002411 adverse Effects 0.000 abstract description 4
- 238000012795 verification Methods 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 3
- 230000001502 supplementing effect Effects 0.000 abstract description 2
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract description 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 240000006274 Actinidia polygama Species 0.000 abstract 1
- 235000016413 Actinidia polygama Nutrition 0.000 abstract 1
- 240000008027 Akebia quinata Species 0.000 abstract 1
- 235000007756 Akebia quinata Nutrition 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 241000331432 Cynanchum wilfordii Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241001211913 Gomphostemma chinense Species 0.000 abstract 1
- 241001506304 Kadsura japonica Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 240000003664 Maclura cochinchinensis Species 0.000 abstract 1
- 240000000249 Morus alba Species 0.000 abstract 1
- 235000008708 Morus alba Nutrition 0.000 abstract 1
- 240000007263 Pinus koraiensis Species 0.000 abstract 1
- 235000011615 Pinus koraiensis Nutrition 0.000 abstract 1
- 241000405911 Rehmannia glutinosa Species 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 241000947588 Russula alutacea Species 0.000 abstract 1
- 240000001638 Scurrula parasitica Species 0.000 abstract 1
- 240000000038 Ziziphus mauritiana Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 244000237330 gutta percha tree Species 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 230000008506 pathogenesis Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 210000003205 muscle Anatomy 0.000 description 30
- 208000006820 Arthralgia Diseases 0.000 description 21
- 208000002193 Pain Diseases 0.000 description 20
- 230000017531 blood circulation Effects 0.000 description 20
- 235000009508 confectionery Nutrition 0.000 description 17
- 230000036407 pain Effects 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 201000010099 disease Diseases 0.000 description 13
- 210000002784 stomach Anatomy 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 11
- 241000411851 herbal medicine Species 0.000 description 11
- 231100000614 poison Toxicity 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 10
- 208000025747 Rheumatic disease Diseases 0.000 description 9
- 239000007789 gas Substances 0.000 description 9
- 208000014674 injury Diseases 0.000 description 9
- 230000001717 pathogenic effect Effects 0.000 description 9
- 230000000552 rheumatic effect Effects 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 8
- 208000011580 syndromic disease Diseases 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 239000003440 toxic substance Substances 0.000 description 8
- 208000002173 dizziness Diseases 0.000 description 7
- 210000003414 extremity Anatomy 0.000 description 7
- 230000008736 traumatic injury Effects 0.000 description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 206010030113 Oedema Diseases 0.000 description 6
- 238000012790 confirmation Methods 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 210000005036 nerve Anatomy 0.000 description 6
- 231100000862 numbness Toxicity 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 208000005392 Spasm Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 230000001537 neural effect Effects 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 208000008035 Back Pain Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- 208000005171 Dysmenorrhea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 206010021118 Hypotonia Diseases 0.000 description 4
- 208000008930 Low Back Pain Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 208000017561 flaccidity Diseases 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000002522 swelling effect Effects 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 3
- 208000004929 Facial Paralysis Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000006011 Stroke Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 3
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 208000002894 beriberi Diseases 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 210000000629 knee joint Anatomy 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 239000002574 poison Substances 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 210000001113 umbilicus Anatomy 0.000 description 3
- MJPMPMZXJIZPRE-UHFFFAOYSA-N 3-butyl-5,6,7,7a-tetrahydro-3h-2-benzofuran-1-one Chemical compound C1CCC=C2C(CCCC)OC(=O)C21 MJPMPMZXJIZPRE-UHFFFAOYSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010006895 Cachexia Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- 208000005577 Gastroenteritis Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- 206010033425 Pain in extremity Diseases 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- FINHMKGKINIASC-UHFFFAOYSA-N Tetramethylpyrazine Chemical compound CC1=NC(C)=C(C)N=C1C FINHMKGKINIASC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000002567 electromyography Methods 0.000 description 2
- 208000026500 emaciation Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- ASUTZQLVASHGKV-JDFRZJQESA-N galanthamine Chemical compound O1C(=C23)C(OC)=CC=C2CN(C)CC[C@]23[C@@H]1C[C@@H](O)C=C2 ASUTZQLVASHGKV-JDFRZJQESA-N 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 230000001617 migratory effect Effects 0.000 description 2
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 230000001228 trophic effect Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- ZOOGRGPOEVQQDX-UUOKFMHZSA-N 3',5'-cyclic GMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=C(NC2=O)N)=C2N=C1 ZOOGRGPOEVQQDX-UUOKFMHZSA-N 0.000 description 1
- XDSYKASBVOZOAG-RAUXBKROSA-N 8(14),15-sandaracopimaradiene Chemical compound C1C[C@@](C)(C=C)C=C2CC[C@H]3C(C)(C)CCC[C@]3(C)[C@H]21 XDSYKASBVOZOAG-RAUXBKROSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000012661 Dyskinesia Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 241000909851 Epiphora Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000004356 Hysteria Diseases 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 206010024453 Ligament sprain Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 206010050031 Muscle strain Diseases 0.000 description 1
- 208000021642 Muscular disease Diseases 0.000 description 1
- 201000009623 Myopathy Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 206010034464 Periarthritis Diseases 0.000 description 1
- 208000010886 Peripheral nerve injury Diseases 0.000 description 1
- 206010060932 Postoperative adhesion Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000011279 abdominal lump Diseases 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 208000012839 conversion disease Diseases 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- NIKHGUQULKYIGE-OTCXFQBHSA-N ent-kaur-16-en-19-oic acid Chemical compound C([C@@H]1C[C@]2(CC1=C)CC1)C[C@H]2[C@@]2(C)[C@H]1[C@](C)(C(O)=O)CCC2 NIKHGUQULKYIGE-OTCXFQBHSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 229960003980 galantamine Drugs 0.000 description 1
- ASUTZQLVASHGKV-UHFFFAOYSA-N galanthamine hydrochloride Natural products O1C(=C23)C(OC)=CC=C2CN(C)CCC23C1CC(O)C=C2 ASUTZQLVASHGKV-UHFFFAOYSA-N 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000027692 gas pain Diseases 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000002984 haematinic effect Effects 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- VCOVNILQQQZROK-UHFFFAOYSA-N isopimaradiene Natural products C1CC(C)(C=C)CC2=CCC3C(C)(C)CCCC3(C)C21 VCOVNILQQQZROK-UHFFFAOYSA-N 0.000 description 1
- NIKHGUQULKYIGE-UHFFFAOYSA-N kaurenoic acid Natural products C1CC2(CC3=C)CC3CCC2C2(C)C1C(C)(C(O)=O)CCC2 NIKHGUQULKYIGE-UHFFFAOYSA-N 0.000 description 1
- 208000016747 lacrimal apparatus disease Diseases 0.000 description 1
- 230000001983 lactogenic effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000001699 lower leg Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 208000001581 lymphogranuloma venereum Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- ZMNSRFNUONFLSP-UHFFFAOYSA-N mephenoxalone Chemical compound COC1=CC=CC=C1OCC1OC(=O)NC1 ZMNSRFNUONFLSP-UHFFFAOYSA-N 0.000 description 1
- 229960001030 mephenoxalone Drugs 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 229960001252 methamphetamine Drugs 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 229960001412 pentobarbital Drugs 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 1
- XDSYKASBVOZOAG-UHFFFAOYSA-N pimaradiene Natural products C1CC(C)(C=C)C=C2CCC3C(C)(C)CCCC3(C)C21 XDSYKASBVOZOAG-UHFFFAOYSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035946 sexual desire Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 210000001364 upper extremity Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种辅助针灸治疗外周神经麻痹的中药冲剂及制备方法,属中药领域。本发明药物有效成分的原料组成为:桑枝、穿破石、当归、大红菇、桂枝、桑寄生、熟地、海松子、甘草、夜交藤、白术、隔山消、大枣、木通根、党参、老虎耳、杜仲、五加皮、川芎、地血香、独活、木天蓼子、牛膝、白僵蚕。本发明选用药材药性相适相辅,针对病因对症下药,有补益肝肾、强筋健骨、健脾益气、补血活血、养血祛风、温经散寒、活血祛瘀、祛风除湿、行气活血、舒筋活络、解毒消肿之功效,吸收效果好,疗效显著,无毒副作用及临床不良反应,经临床验证对外周神经麻痹治愈率较高。
Description
所属技术领域
本发明涉及中药领域,尤其涉及一种辅助针灸治疗外周神经麻痹的中药冲剂及制备方法。
背景技术
外周神经麻痹是临床常见的症状之一,是外周神经损伤的常见症状,其常见发病部位有面部、口舌、四肢、指端、皮肤、肩背、胸腹等处,肌体部位不同,肌体出现的病症也有所差异,通常会出现神经、肌肉的麻痹,引起相应神经支配部位的运动障碍,如面神经是外周神经中最易麻痹的神经,面神经麻痹会引起面部歪斜,表情动作消失,眼裂变大而不能闭合,口角歪斜鼓气漏气等。
目前,西医对于外周神经麻痹并无特效药物,通常采取营养神经药物,血管扩张剂等进行治疗,严重者采用激素及加兰他敏等西药进行治疗。虽有一定的疗效,但是西药治疗外周神经麻痹周期较长,随着疾病的发展,药量需要逐渐增加,但是药物效果会随着耐药性的产生逐渐降低甚至消失,且对身体有很大的副作用,所以通常只采用营养神经药物做辅助治疗手段。
外周神经麻痹属于中医“痹证”、“痿证”等范畴,本病多因机体正气不足,脉络空虚,风、寒、湿邪侵袭人体,致气血痹阻、运行不畅、脉络不通、筋脉失养所致。对于外周神经麻痹针灸治疗是常用的治疗方法,针灸在祛风散寒、疏通经络、活血化瘀、解痉止痛等方面功效显著,另针灸治疗简单方便,成本低,副作用少,获得了广泛肯定。但有些病症使用针灸治疗时,在取穴上有所不便,同时针灸在补益方面有其局限性,因此使用中药内服辅助针灸治疗本病疗程更短,疗效更为显著。故本发明根据病因对症下药,具有补益肝肾、强筋健骨、健脾益气、补血活血、养血祛风、温经散寒、活血祛瘀、祛风除湿、行气活血、舒筋活络、解毒消肿之功效,辅助针灸治疗疗效显著,吸收效果好,无毒副作用及临床不良反应,经临床验证对外周神经麻痹治愈率较高。
发明内容
本发明提供了一种辅助针灸治疗外周神经麻痹的中药冲剂及制备方法,具有补益肝肾、强筋健骨、健脾益气、补血活血、养血祛风、温经散寒、活血祛瘀、祛风除湿、行气活血、舒筋活络、解毒消肿之功效,治病求源标本兼治,对各种原因引起的外周神经麻痹均具有很好的疗效。
为实现上述目的,本发明的技术方案实施如下:
一种辅助针灸治疗外周神经麻痹的中药冲剂,制成所述药物有效成分的原料组成及重量份数为:
桑枝70~84份、穿破石67~80份、当归63~77份、大红菇60~73份
桂枝57~70份、桑寄生54~67份、熟地51~64份、海松子48~60份
甘草45~57份、夜交藤42~54份、白术39~50份、隔山消36~47份
大枣33~44份、木通根30~41份、党参27~38份、老虎耳24~35份
杜仲21~32份、五加皮18~29份、川芎15~26份、地血香12~23份
独活8~20份、木天蓼子5~16份、牛膝3~13份、白僵蚕1~10份。
制成所述药物有效成分的原料组成及重量份数为:
桑枝74~80份、穿破石70~77份、当归66~74份、大红菇63~70份、
桂枝60~67份、桑寄生57~64份、熟地54~60份、海松子51~57份、
甘草48~54份、夜交藤45~51份、白术42~47份、隔山消39~44份、
大枣36~41份、木通根33~38份、党参30~35份、老虎耳27~32份、
杜仲24~30份、五加皮21~26份、川芎18~23份、地血香15~20份、
独活10~16份、木天蓼子8~13份、牛膝5~10份、白僵蚕2~7份。
制成所述药物有效成分的原料组成及重量份数为:
桑枝77份、穿破石74份、当归70份、大红菇67份、
桂枝64份、桑寄生61份、熟地57份、海松子54份、
甘草51份、夜交藤48份、白术45份、隔山消42份、
大枣38份、木通根35份、党参32份、老虎耳29份、
杜仲26份、五加皮23份、川芎20份、地血香18份、
独活14份、木天蓼子10份、牛膝7份、白僵蚕4份。
一种辅助针灸治疗外周神经麻痹的中药冲剂的制备方法,包括以下工艺步骤:
(1)将桑枝、当归、大红菇、桂枝、海松子、夜交藤、白术、隔山消、大枣、党参、老虎耳、五加皮、木天蓼子洗净、晾干后混合均匀,放入容器中,在容器中加入6~8倍量的水,加热煮沸2~3小时,冷却后取浸液;在剩余的药渣中再加入4~6倍量的水,加热煮沸1~2小时,冷却后取浸液;合并两次所得浸液,加热,蒸发浓缩为相对密度1.15~1.25的稠膏,备用;
(2)将穿破石、桑寄生、熟地、木通根、杜仲、地血香、独活、牛膝放入容器中,加入3~5倍量的绍兴黄酒,煮沸后放凉,继续浸泡3~5小时,取浸液;在剩余的药渣中再加入2~4倍量的绍兴黄酒,煮沸后放晾,继续浸泡2~4小时,取浸液;合并两次所得浸液,加蒸蒸发浓缩为相对密度1.10~1.20的稠膏,备用;
(3)取净甘草片,加入炼熟的蜂蜜与少许开水,拌匀后稍闷,置炒制容器内,文火炒至黄色至深黄色,不粘手时取出,放凉,粉碎研末,过100目细筛,得细粉,备用;
(4)取川芎片用黄酒喷洒均匀,稍闷,置锅内炒至微焦为度,取出放凉,粉碎研末,过100目细筛,得细粉,备用;
(5)用麸皮撒于热锅中,候烟冒起,倒入僵蚕,炒至黄色,取出筛去麸皮,放凉,粉碎研末,过100目细筛,得细粉,备用;
(6)将步骤(1)、步骤(2)所得的稠膏,与步骤(3)、步骤(4)、步骤(5)中所得的细粉混合,加辅料蔗糖和糊精混合均匀制成颗粒,干燥、整粒后,封装成每袋10g的中药冲剂。
本发明所用中药的药性如下:
桑枝:味苦;性平。入肺;肾二经。祛风湿;利关节;行水气。治风寒湿痹;四肢拘挛;脚气浮肿;中风半身不遂;肌体风痒;用于肩臂、关节酸痛麻木。《本草图经》载:“疗遍体风痒干燥,脚气风气,四肢拘挛。”现代医学研究证实,桑枝对肩周炎有明显疗效,能防治II区屈指肌腱术后黏连。
穿破石:味淡;微苦;性凉。祛风通络;清热除湿;解毒消肿。主治风湿痹痛;跌打损伤;黄疽;腮腺炎;肺结核;胃和十二指肠溃疡;淋浊;蛊胀;闭经;劳伤咳血;疗疮痈肿。《闽东本草》:健脾益胃,舒筋活络,祛风湿,去瘀血。治腰痛、关节痛,虚劳黄肿,脾虚泄泻。
当归:味甘;辛;性温。归肝、心、脾经。补血活血;调经止痛;润肠通便。主治血虚萎黄;眩晕心悸;虚寒腹痛;风湿痹痛;跌扑损伤;痈疽疮疡。《本草正》载:“其味甘而重,故专能补血,其气轻而辛,故又能行血,能养营养血,补气生精,安五脏,强形体,益神志,凡有形虚损之病,无所不宜。”现代医学研究证实,当归具有抗菌、消炎作用,对慢性风湿关节炎急性发作有明显的抑制作用。
大红菇:味甘;性微温。养血;逐瘀;祛风。主治血虚萎黄;产后恶露不尽;关节酸痛。
桂枝:味辛;甘;性温。入膀胱;心;肺经。散寒解表;温通经脉;通阳化气。主治风寒表证;寒湿痹痛;四肢厥冷;经闭痛经;癓瘕结块;胸痹;心悸;痰饮;小便不利。《长沙药解》载:“入肝家而行血分,定经络而达荣郁。善解风邪,最调木气。升清阳之脱陷,降浊阴之冲逆,舒筋脉之急挛;利关节之壅阻。入肝胆而散遏抑,极止痛楚,通经络而开痹涩,甚去湿寒。能止奔豚,更安惊悸。”现代医学研究证实,桂枝能有效扩张血管、促进发汗,所含的桂皮醛、桂皮酸钠有解热、镇痛、镇静、抗惊厥作用,此外桂枝还有抗菌、抗病毒的功效。
桑寄生:味苦;甘;性平。入肝;肾经。补肝肾;强筋骨;祛风湿;安胎。主治腰膝酸痛;筋骨痿弱;肢体偏枯;风湿痹痛;头晕目眩;胎动不安,崩漏下血。《本草求真》载:“缘肾主骨,发主血,苦人肾,肾得补则筋骨有力,不致屡痔而酸感矣。甘补血,血得补则发受其灌荫而不桔脱落矣。故凡内而腰痛、筋骨笃疾、胎堕,外而金疮、肌肤风湿。”现代医学研究证实,桑寄生有降压、抗心律失常、增加冠脉流量、改善冠脉循环、增强心脏收缩力、降低心肌耗氧、抑制血小板聚集,抗血栓形成、改善微循环、抗肿瘤作用、治疗肝炎等诸多功效。
熟地:味甘;性温;归肝;肾经。补血滋润;益精填髓。主治血虎萎黄;眩晕心悸;肝肾阴亏;腰膝酸软;肾虚喘促。《本草汇言》载:“久病阴伤,新产血败,在所必需者也。”现代医学研究证实,熟地可增强GSH-Px活性,降低血清中LPO的含量,提高血浆AD浓度,此外与骨髓造血系统亦有密切相关的作用。
海松子:味甘;性微温。归肝;肺;大肠经。润燥,养血,祛风。主治肺燥干咳,大便虚秘,诸风头眩,骨节风,风痹。并有润泽皮肤,敷荣毛发的功能。《日华子本草》:逐风痹寒气,虚羸少气,补不足,润皮肤,肥五脏。
甘草:味甘;性平。归心;肺;脾;胃经。补脾益气;清热解毒;祛痰止咳;缓急止痛;调和诸药。主治脾胃虚弱;倦怠乏力;心悸气短;咳嗽痰多;脘腹四脚挛急疼痛;痈肿疮毒;缓解药物毒性。《本草纲目》载:“诸药中甘草为君。治七十二种乳石毒,解一千二百般草本毒,调和从药有功。”现代医学研究证实,甘草有较强的解毒作用,还有抗溃疡、抗炎症、镇痉镇咳、降血压、降血脂、抗癌作用,广泛用于治疗咽喉炎、喉炎、气管炎、支气管炎、哮喘、咳嗽、咳血等疾病,此外还具有抗胃溃疡、抗胃炎作用。
夜交藤:味甘;微苦;性平。入心;肝经。养心安神;祛风;通络。主治失眠;多梦;血虚身痛;肌肤麻木;风湿痹痛;风疹瘙痒。《饮片新参》载:“养肝肾,止虚汗,安神催眠,补中气,行经络,通血脉,治劳伤。”现代医学研究证实,夜交藤含有大黄素、大黄素甲醚,与戊巴比妥钠呈协同作用,有显著的镇静、催眠作用,尤其是延长慢波睡眠时相。
白术:味苦;甘;性温。归脾;胃经。健脾益气;燥湿利水;止汗;安胎。主治脾气虚弱;神疲乏力;食少腹胀;大便溏薄;水饮内停;小便不利;水肿;痰饮眩晕;湿痹酸痛;气虚自汗;胎动不安。《本经逢原》载:“术,生用有除湿益燥,消痰利水,治风寒湿痹,死肌痉疸,散腰脐间血,及冲脉为病,逆气里急之功;制熟则有和中补气,止渴生津,止汗除热,进饮食,安胎之效。”现代医学研究证实,白术具有利尿、降血糖、强壮、抗凝血、抗肿瘤、抗菌、促进造血和蛋白质合成的作用。
隔山消:味甘;微苦;性微温;归脾;胃;肾经。补肝肾;强筋骨;健脾胃;解毒。主肝肾两虚;头昏眼花;失眠健忘;须发早白;阳痿;遗精;腰膝酸软;脾虚不运;脘腹胀满;性欲不振;泄泻;产后乳少;鱼口疮毒。《陕西中草药》:滋阴养血,健脾顺气,镇静止痛,催乳。治胃痛腹胀,虚劳,肾虚腰痛,阳萎,小儿痞块,白带,乳汁不足。
大枣:味甘;温。归脾;胃经。补脾胃;益气血;安心神;调营卫;和药性。主治脾胃虚弱;气血不足;食少便溏;倦怠乏力;心悸失眠;妇人脏躁;营卫不和。《本草汇言》:沈氏曰,此药甘润膏凝,善补阴阳、气血、津液、脉络、筋俞、骨髓,一切虚损,无不宜之。如龙谭方治惊悸怔忡,健忘恍惚,志意昏迷,精神不守,或中气不和,饮食无味,百体懒重,肌肉瘦,此属心、脾二藏元神亏损之证,必用大枣治之。佐用陈皮,调畅中脘虚滞之痰。
木通根:味苦;性平;归肝;肾经。祛风通络;利水消肿;行气活血;补肝肾;强筋骨。主治风湿痹痛;跌打损伤;经闭;疝气;睾丸肿痛;脘腹胀闷;小便不利;带下;虫蛇咬伤。《浙江民间常用草药》:祛风止痛,行气活血,利尿解毒。
党参:味甘;性平。归脾;肺经。健脾补肺;益气生津。主治脾胃虚弱;食少便溏;四肢乏力;肺虚喘咳;气短自汗;气血两亏诸证。《德配本草》载:“清肺金,补元气,开声音,助筋力。”现代医学研究证实,党参能调节胃肠运动、抗溃疡、增强免疫功能,对兴奋和抑制两种神经过程都有影响,能升高红细胞、血红蛋白、网织红细胞,还有延缓衰老和抗氧化、抗辐射、降压的作用。
老虎耳:益气血;祛风湿;通经络;消肿毒。主治气亏血虚;风湿痹痛;拘挛麻木;刀伤出血;口疮。
杜仲:味甘;微辛;性温。入肝;肾经。补肝肾;强筋骨。主治腰脊酸疼;风湿痹痛。《本草纲目》:杜仲,古方只知滋肾,惟王好古言是肝经气分药,润肝燥,补肝虚,发昔人所未发也。盖肝主筋,肾主骨,肾充则骨强,肝充则筋健,屈伸利用,皆属于筋。杜仲色紫而润,味甘微辛,其气温平,甘温能补,微辛能润,故能入肝而补肾,子能令母实也。现代医学研究证实,杜仲对神经中枢有镇静作用,能增强细胞的免疫功能,促进皮质醇分泌和血浆中cAMP和cGMP代谢。
五加皮:味辛、苦,性温。归肝、肾经。祛风湿;补肝肾;强筋骨;活血脉。主风寒湿痹;腰膝疼痛;筋骨痿软;小儿行迟;体虚赢弱;跌打损伤;骨折;水肿;脚气;阴下湿痒。《本草再新》:化痰除湿,养肾益精,去风消水,理脚气腰痛,治疮疥诸毒。现代研究证明,本品具有抗肿瘤、抗疲劳、降低全血粘度、防止动脉粥样硬化形成等作用。
川芎:味辛;性温。归肝;胆;心包经。活血祛瘀;行气开郁;祛风止痛。主治癓瘕肿块;胸胁疼痛;头痛眩晕;风寒湿痹;跌打损伤;痈疽疮疡。《本草正》载:“散风寒,治痛,破瘀蓄,通血脉,解结气,逐疼痛,排脓消肿,逐血通经。”现代医学科学研究发现,川芎提取液对抑制白血病细胞有一定作用,制剂有一定的抗菌作用,尤其是对伤寒杆菌、副伤寒杆菌、霍乱弧菌、绿脓杆菌及致病性皮肤真菌等均有抑制作用,川芎所含的川芎嗪、阿魏酸纳具有活血化瘀功效,可扩张冠状动脉,增进冠脉流量,缓解心绞痛,并具有抗血栓形成作用,所含的川芎内酯有平滑肌解痉和抑制肠肌、子宫收缩等作用。
地血香:味辛;苦;性温。归脾;胃;肝经。祛风除湿;行气止痛;舒筋活络。主治风湿痹痛;胃痛;腹痛;痛经;产后腹痛;跌打损伤;慢性腰腿痛。《广西中草药》:活血散瘀,行气止痛,祛风湿。治跌打损伤,风湿骨痛,痛经,产后腹痛,急慢性胃肠炎。
独活:味辛;苦;性温。入肝;肾经。祛风除湿;舒筋活络;和血止痛。主治风湿疼痛;腰膝酸痛;四肢痿痹;腰肌劳损;鹤膝风;手足扭伤肿痛;骨折;头风;头痛;牙痛。《本草新编》载:“味甘辛,气温,可升可降,阳中之阴,无毒。虽有上下之分,而补血则一。入心、脾、肝三脏,但其性甚动,入之补气药中则补气,入之补血药中则补血,无定功也。”现代医学研究证实,独活所含的贝壳杉烯酸和海松二烯酸有镇痛作用,镇痛、降温、延长戊巴比妥麻醉期作用,且能抑制去氧麻黄碱所增强的运动性,促进蛋白质合成,对DNA、RNA的合成有促进作用,能降低麝香草酚浊度,增加红细胞运输氧的能力,抑制氧化反应和自由基反应对组织的损害。
木天蓼子:味辛;苦;性温。归肝;肾经。祛风通络;活血行气;散寒止痛。主治中风口面歪斜;痃癖腹痛;疝气。《药性论》:"治中贼风,口面歪斜,主冷痃癖气块,女子虚劳。"
牛膝:味苦;酸;性平。归肝;肾经。补肝肾;强筋骨;活血通经;引火下行;利尿通淋。主治腰膝酸痛;下肢痿软;血滞经闭;痛经;产后血瘀腹痛;徵瘕;胞衣不下;热淋;血淋;跌打损伤;痈肿恶疮;咽喉肿痛。朱震亨:牛膝,能引诸药下行,筋骨痛风在下者,宜加用之。
白僵蚕:味辛;咸;性平。归肝;肺;胃经。祛风止痉;化痰散结;解毒利咽。主治:惊痫抽搐;中风口眼歪斜;偏正头痛;咽喉肿痛;瘰疬;痄腮;风疹;疮毒。《药性论》:《日华子》、苏颂、元素皆取其性属阳,风热为阳邪,能入皮肤经络,发散诸邪热气也。
本发明与现有技术相比,具有以下有益效果:
本发明选用药材,药性相适相辅,针对病因对症下药,有补益肝肾、强筋健骨、健脾益气、补血活血、养血祛风、温经散寒、活血祛瘀、祛风除湿、行气活血、舒筋活络、解毒消肿之功效,吸收效果好,疗效显著,无毒副作用及临床不良反应,经临床验证对外周神经麻痹治愈率较高。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明药物有效成分的原料组成及重量为:
桑枝70~84份、穿破石67~80份、当归63~77份、大红菇60~73份、
桂枝57~70份、桑寄生54~67份、熟地51~64份、海松子48~60份、
甘草45~57份、夜交藤42~54份、白术39~50份、隔山消36~47份、
大枣33~44份、木通根30~41份、党参27~38份、老虎耳24~35份、
杜仲21~32份、五加皮18~29份、川芎15~26份、地血香12~23份、
独活8~20份、木天蓼子5~16份、牛膝3~13份、白僵蚕1~10份。
本发明药物制备方法的工艺步骤为:
(1)将桑枝、当归、大红菇、桂枝、海松子、夜交藤、白术、隔山消、大枣、党参、老虎耳、五加皮、木天蓼子洗净、晾干后混合均匀,放入容器中,在容器中加入6~8倍量的水,加热煮沸2~3小时,冷却后取浸液;在剩余的药渣中再加入4~6倍量的水,加热煮沸1~2小时,冷却后取浸液;合并两次所得浸液,加热,蒸发浓缩为相对密度1.15~1.25的稠膏,备用;
(2)将穿破石、桑寄生、熟地、木通根、杜仲、地血香、独活、牛膝放入容器中,加入3~5倍量的绍兴黄酒,煮沸后放凉,继续浸泡3~5小时,取浸液;在剩余的药渣中再加入2~4倍量的绍兴黄酒,煮沸后放晾,继续浸泡2~4小时,取浸液;合并两次所得浸液,加蒸蒸发浓缩为相对密度1.10~1.20的稠膏,备用;
(3)取净甘草片,加入炼熟的蜂蜜与少许开水,拌匀后稍闷,置炒制容器内,文火炒至黄色至深黄色,不粘手时取出,放凉,粉碎研末,过100目细筛,得细粉,备用;
(4)取川芎片用黄酒喷洒均匀,稍闷,置锅内炒至微焦为度,取出放凉,粉碎研末,过100目细筛,得细粉,备用;
(5)用麸皮撒于热锅中,候烟冒起,倒入僵蚕,炒至黄色,取出筛去麸皮,放凉,粉碎研末,过100目细筛,得细粉,备用;
(6)将步骤(1)、步骤(2)所得的稠膏,与步骤(3)、步骤(4)、步骤(5)中所得的细粉混合,加辅料蔗糖和糊精混合均匀制成颗粒,干燥、整粒后,封装成每袋10g的中药冲剂。
用法用量:每日3次每次1袋,饭前半小时以开水冲服,7天为1个疗程,孕妇忌用。
实施例2
本发明药物有效成分的原料组成及重量为:
桑枝74~80份、穿破石70~77份、当归66~74份、大红菇63~70份、
桂枝60~67份、桑寄生57~64份、熟地54~60份、海松子51~57份、
甘草48~54份、夜交藤45~51份、白术42~47份、隔山消39~44份、
大枣36~41份、木通根33~38份、党参30~35份、老虎耳27~32份、
杜仲24~30份、五加皮21~26份、川芎18~23份、地血香15~20份、
独活10~16份、木天蓼子8~13份、牛膝5~10份、白僵蚕2~7份。
本实施例的药物制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明药物有效成分的原料组成及重量为:
桑枝77份、穿破石74份、当归70份、大红菇67份、
桂枝64份、桑寄生61份、熟地57份、海松子54份、
甘草51份、夜交藤48份、白术45份、隔山消42份、
大枣38份、木通根35份、党参32份、老虎耳29份、
杜仲26份、五加皮23份、川芎20份、地血香18份、
独活14份、木天蓼子10份、牛膝7份、白僵蚕4份。
本实施例的药物制备方法工艺步骤及用法用量与实施例1相同。
临床资料:
1、病例选择
选择我院或外院确诊的外周神经麻痹患者60例临床观察,病人随机分成两组。治疗组30例,其中男性17例,女性13例,年龄31~67岁,平均年龄47.6岁。对照组30例,其中男性16例,女性14例,年龄29~67岁,平均年龄48.1岁。两组资历基本一致,无显著差异,具有可比性。
2、治疗组及对照组均根据患者诊断出的病症,对症予以常规针灸治疗。治疗组患者在针灸治疗之外,加服本发明药物,每日3次每次1袋,饭前半小时以开水冲服,7天为1个疗程,服用3个疗程。
3、疗效判定:
(1)治愈:临床症状完全消失,肌肉外形及肌电图检查恢复正常。
(2)好转:临床症状明显缓解,肌肉外形及肌电图检查结果明显好转。
(3)无效:症状同施治前无明显差异。
4、结果
治疗组治愈率63.3%、总有效率93.3%,对照组治愈率43.3%、总有效率83.3%,两组疗效比较,差异具有统计学意义(P<0.05),故治疗组对于本病的疗效明显优于对照组。
表1两组患者临床疗效比较
典型病例举例:
1、岳××,男,55岁。该患者睡觉时右脚露在被外,早上起床后,突然出现右下肢麻木无力,右足下垂,右下肢小腿外侧及足背区感觉减退,背屈不能,活动困难,后来来院问诊,诊断为外周神经麻痹,经进行对症针灸治疗,并服用本发明所述中药1个疗程后,上述症状完全消失,临床检查恢复正常,已痊愈。
2、张××,女,37岁。患者因风寒感冒,早上起床后发现右侧面部不适,口角歪斜,右眼无法闭合,迎风流泪,吐字不清。后来来院问诊,诊断为外周面神经麻痹,经进行对症针灸治疗,并服用本发明所述中药2个疗程后,上述症状完全消失,临床检查恢复正常,已痊愈。
3、徐××,男,57岁。患者过量饮酒后,开窗未盖被睡着,早上醒后,身体乏力,右手手腕下垂不能抬起,小臂外侧感觉减退,手指不能伸直外展。后来来院问诊,诊断为外周面神经麻痹,经进行对症针灸治疗,并服用本发明所述中药1个疗程后,上述症状基本消失,遵医嘱继续服用1个疗程后,上述症状完全消失,临床检查恢复正常,已痊愈。
《素问·痹论》言:“风寒湿三气杂至,合而为痹。”本发明认为痹证的形成多以正气虚衰为内因,风寒湿邪为外因,故治疗当标本兼顾,扶正祛邪。本发明所述中药,根据病因对症下药,方中桑寄生、隔山消、杜仲、五加皮可补益肝肾,强壮筋骨;方中党参、白术可健脾益气;方中当归、熟地可补血活血;方中大红菇、海松子可养血祛风;方中大枣可益气血、调营卫;方中川芎可活血祛瘀、祛风止痛;方中桂枝可散寒解表、温通经脉;方中白僵蚕可祛风止痉、化痰散结;方中穿破石、夜交藤、木通根、木天蓼子、老虎耳可祛风通络、行气活血、解毒消肿;方中地血香、独活可祛风除湿、舒筋活络;方中桑枝可祛风邪而舒筋络,尤善走上肢;方中牛膝善行走下,可引药下行;方中甘草可调和诸药;方中诸药合用,可共奏补益肝肾、强筋健骨、健脾益气、补血活血、养血祛风、温经散寒、活血祛瘀、祛风除湿、行气活血、舒筋活络、解毒消肿之功效,辅助针灸治疗疗效显著,吸收效果好,无毒副作用及临床不良反应,经临床验证对外周神经麻痹治愈率较高。
Claims (4)
1.一种辅助针灸治疗外周神经麻痹的中药冲剂,其特征在于:制成所述药物有效成分的原料组成及重量份数为:
桑枝70~84份、穿破石67~80份、当归63~77份、大红菇60~73份、
桂枝57~70份、桑寄生54~67份、熟地51~64份、海松子48~60份、
甘草45~57份、夜交藤42~54份、白术39~50份、隔山消36~47份、
大枣33~44份、木通根30~41份、党参27~38份、老虎耳24~35份、
杜仲21~32份、五加皮18~29份、川芎15~26份、地血香12~23份、
独活8~20份、木天蓼子5~16份、牛膝3~13份、白僵蚕1~10份。
2.根据权利要求1所述的一种辅助针灸治疗外周神经麻痹的中药冲剂,其特征在于:制成所述药物有效成分的原料组成及重量份数为:
桑枝74~80份、穿破石70~77份、当归66~74份、大红菇63~70份、
桂枝60~67份、桑寄生57~64份、熟地54~60份、海松子51~57份、
甘草48~54份、夜交藤45~51份、白术42~47份、隔山消39~44份、
大枣36~41份、木通根33~38份、党参30~35份、老虎耳27~32份、
杜仲24~30份、五加皮21~26份、川芎18~23份、地血香15~20份、
独活10~16份、木天蓼子8~13份、牛膝5~10份、白僵蚕2~7份。
3.根据权利要求1所述的一种辅助针灸治疗外周神经麻痹的中药冲剂,其特征在于:制成所述药物有效成分的原料组成及重量份数为:
桑枝77份、穿破石74份、当归70份、大红菇67份、
桂枝64份、桑寄生61份、熟地57份、海松子54份、
甘草51份、夜交藤48份、白术45份、隔山消42份、
大枣38份、木通根35份、党参32份、老虎耳29份、
杜仲26份、五加皮23份、川芎20份、地血香18份、
独活14份、木天蓼子10份、牛膝7份、白僵蚕4份。
4.一种辅助针灸治疗外周神经麻痹的中药冲剂的制备方法,其特征在于:包括以下工艺步骤:
(1)将桑枝、当归、大红菇、桂枝、海松子、夜交藤、白术、隔山消、大枣、党参、老虎耳、五加皮、木天蓼子洗净、晾干后混合均匀,放入容器中,在容器中加入6~8倍量的水,加热煮沸2~3小时,冷却后取浸液;在剩余的药渣中再加入4~6倍量的水,加热煮沸1~2小时,冷却后取浸液;合并两次所得浸液,加热,蒸发浓缩为相对密度1.15~1.25的稠膏,备用;
(2)将穿破石、桑寄生、熟地、木通根、杜仲、地血香、独活、牛膝放入容器中,加入3~5倍量的绍兴黄酒,煮沸后放凉,继续浸泡3~5小时,取浸液;在剩余的药渣中再加入2~4倍量的绍兴黄酒,煮沸后放晾,继续浸泡2~4小时,取浸液;合并两次所得浸液,加蒸蒸发浓缩为相对密度1.10~1.20的稠膏,备用;
(3)取净甘草片,加入炼熟的蜂蜜与少许开水,拌匀后稍闷,置炒制容器内,文火炒至黄色至深黄色,不粘手时取出,放凉,粉碎研末,过100目细筛,得细粉,备用;
(4)取川芎片用黄酒喷洒均匀,稍闷,置锅内炒至微焦为度,取出放凉,粉碎研末,过100目细筛,得细粉,备用;
(5)用麸皮撒于热锅中,候烟冒起,倒入僵蚕,炒至黄色,取出筛去麸皮,放凉,粉碎研末,过100目细筛,得细粉,备用;
(6)将步骤(1)、步骤(2)所得的稠膏,与步骤(3)、步骤(4)、步骤(5)中所得的细粉混合,加辅料蔗糖和糊精混合均匀制成颗粒,干燥、整粒后,封装成每袋10g的中药冲剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510970171.1A CN105381128A (zh) | 2015-12-21 | 2015-12-21 | 一种辅助针灸治疗外周神经麻痹的中药冲剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510970171.1A CN105381128A (zh) | 2015-12-21 | 2015-12-21 | 一种辅助针灸治疗外周神经麻痹的中药冲剂及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105381128A true CN105381128A (zh) | 2016-03-09 |
Family
ID=55414304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510970171.1A Pending CN105381128A (zh) | 2015-12-21 | 2015-12-21 | 一种辅助针灸治疗外周神经麻痹的中药冲剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105381128A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105770536A (zh) * | 2016-04-01 | 2016-07-20 | 青岛智信天成科技发展有限公司 | 用于老年人健康调理的中药保健冲剂及制备方法 |
CN105853898A (zh) * | 2016-03-28 | 2016-08-17 | 于秀 | 一种用于膝关节康复护理的中药熏洗粉剂及制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104666955A (zh) * | 2015-03-31 | 2015-06-03 | 华梅 | 一种治疗面神经麻痹的中药酒及其制备方法 |
CN104958542A (zh) * | 2015-08-05 | 2015-10-07 | 王曰军 | 一种用于治疗面神经麻痹的中药制剂及制备方法 |
-
2015
- 2015-12-21 CN CN201510970171.1A patent/CN105381128A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104666955A (zh) * | 2015-03-31 | 2015-06-03 | 华梅 | 一种治疗面神经麻痹的中药酒及其制备方法 |
CN104958542A (zh) * | 2015-08-05 | 2015-10-07 | 王曰军 | 一种用于治疗面神经麻痹的中药制剂及制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105853898A (zh) * | 2016-03-28 | 2016-08-17 | 于秀 | 一种用于膝关节康复护理的中药熏洗粉剂及制备方法 |
CN105770536A (zh) * | 2016-04-01 | 2016-07-20 | 青岛智信天成科技发展有限公司 | 用于老年人健康调理的中药保健冲剂及制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103520654B (zh) | 一种用于治疗膝骨关节炎的中药组合物及其制备方法 | |
CN101810685B (zh) | 一种治疗膝关节炎症的中药组合物及其制备方法 | |
CN104666579A (zh) | 一种治疗膝关节滑膜炎的中药组合物及其制备方法 | |
CN105250887A (zh) | 用于icu重症肌无力治疗与护理的中药冲剂及制备方法 | |
CN105056133A (zh) | 一种用于治疗纤维肌痛综合症的中药丸剂及制备方法 | |
CN105148039A (zh) | 一种用于缓解肿瘤放疗后反应的中药药丸及制备方法 | |
CN105148249A (zh) | 一种用于治疗经行浮肿的中药丸剂及制备方法 | |
CN104721628A (zh) | 一种用于脑震荡康复治疗的中药药丸及制备方法 | |
CN104784415A (zh) | 一种用治疗急性出疹性传染疾病的中药丸剂及制备方法 | |
CN104940868A (zh) | 一种治疗颈椎病的中药配方及颈椎贴 | |
CN102940745B (zh) | 一种用于治疗眼睑痉挛的丸剂 | |
CN105381128A (zh) | 一种辅助针灸治疗外周神经麻痹的中药冲剂及制备方法 | |
CN101322756B (zh) | 用于推拿按摩治疗腰椎病症的药物及其制备方法 | |
CN103446310B (zh) | 一种治疗腰腿痛的中药药浴及其制备方法 | |
CN105999110A (zh) | 一种用于治疗女性慢性盆腔疼痛的中药冲剂及制备方法 | |
CN105853898A (zh) | 一种用于膝关节康复护理的中药熏洗粉剂及制备方法 | |
CN105250569A (zh) | 一种用于治疗末梢神经炎的中药丸剂及制备方法 | |
CN102935156B (zh) | 一种治疗骨质增生症的丸剂 | |
CN105998555A (zh) | 一种用于产后关节痛缓解与护理的中药丸剂及制备方法 | |
CN105381127A (zh) | 一种辅助针灸治疗周围性面瘫的中药冲剂及制备方法 | |
CN105381441A (zh) | 一种用于防治妊娠水肿的中药胶囊剂及制备方法 | |
CN104740304A (zh) | 一种用于治疗肩周炎的中药丸剂及制备方法 | |
CN105362402A (zh) | 一种治疗气虚的泡脚药、其制备方法及应用 | |
CN104524422A (zh) | 一种治疗男性乳房发育症的药丸及制备方法 | |
CN104189714A (zh) | 一种治疗冠心病的中药胶囊 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160309 |